Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
31.50
+0.08 (0.25%)
At close: Jun 26, 2026, 4:00 PM EDT
31.39
-0.11 (-0.35%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 182 employees as of December 31, 2025. The number of employees increased by 1 or 0.55% compared to the previous year.
Employees
182
Change (1Y)
1
Growth (1Y)
0.55%
Revenue / Employee
$3,279,989
Profits / Employee
$1,216,060
Market Cap
3.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 182 | 1 | 0.55% |
| Dec 31, 2024 | 181 | 14 | 8.38% |
| Dec 31, 2023 | 167 | 85 | 103.66% |
| Dec 31, 2022 | 82 | 6 | 7.89% |
| Dec 31, 2021 | 76 | 2 | 2.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 507 |
| Arcutis Biotherapeutics | 354 |
| Structure Therapeutics | 233 |
| Relay Therapeutics | 193 |
CPRX News
- 18 days ago - Catalyst Pharmaceuticals Proxy statement: Proxy filing - Filings
- 4 weeks ago - Catalyst Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 4 weeks ago - Catalyst Pharmaceuticals Proxy statement: Proxy filing - Filings
- 6 weeks ago - Catalyst Pharmaceuticals Proxy statement: Proxy filing - Filings
- 6 weeks ago - Catalyst Pharmaceuticals reports Q1 non-GAAP EPS 79c, consensus 64c - TheFly
- 6 weeks ago - Catalyst Pharmaceuticals not providing forward-looking guidance - TheFly
- 6 weeks ago - Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Catalyst Pharmaceuticals Quarterly report: Q1 2026 - Filings